Company page

Oxford Biomedica Plc

Oxford Biomedica Plc is a public company listed on the UK market under the ticker OXB, with a market capitalization of approximately £970 million. The company focuses on gene and cell therapy, leveraging its expertise to develop innovative treatments for various diseases. Oxford Biomedica aims to advance its position in the biopharmaceutical industry through strategic partnerships and cutting-edge research.